La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa.

Identifieur interne : 003F38 ( Main/Merge ); précédent : 003F37; suivant : 003F39

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa.

Auteurs : O. Rascol [France] ; D J Brooks ; A D Korczyn ; P P De Deyn ; C E Clarke ; A E Lang

Source :

RBID : pubmed:10816186

English descriptors

Abstract

There is debate about whether the initial treatment for patients with Parkinson's disease should be levodopa or a dopamine agonist.

DOI: 10.1056/NEJM200005183422004
PubMed: 10816186

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:10816186

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa.</title>
<author>
<name sortKey="Rascol, O" sort="Rascol, O" uniqKey="Rascol O" first="O" last="Rascol">O. Rascol</name>
<affiliation wicri:level="3">
<nlm:affiliation>Clinical Investigation Center, Neuropharmacology Unit, INSERM Unité 455, University Hospital, Toulouse, France. rascol@cict.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Clinical Investigation Center, Neuropharmacology Unit, INSERM Unité 455, University Hospital, Toulouse</wicri:regionArea>
<placeName>
<region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Brooks, D J" sort="Brooks, D J" uniqKey="Brooks D" first="D J" last="Brooks">D J Brooks</name>
</author>
<author>
<name sortKey="Korczyn, A D" sort="Korczyn, A D" uniqKey="Korczyn A" first="A D" last="Korczyn">A D Korczyn</name>
</author>
<author>
<name sortKey="De Deyn, P P" sort="De Deyn, P P" uniqKey="De Deyn P" first="P P" last="De Deyn">P P De Deyn</name>
</author>
<author>
<name sortKey="Clarke, C E" sort="Clarke, C E" uniqKey="Clarke C" first="C E" last="Clarke">C E Clarke</name>
</author>
<author>
<name sortKey="Lang, A E" sort="Lang, A E" uniqKey="Lang A" first="A E" last="Lang">A E Lang</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2000">2000</date>
<idno type="RBID">pubmed:10816186</idno>
<idno type="pmid">10816186</idno>
<idno type="doi">10.1056/NEJM200005183422004</idno>
<idno type="wicri:Area/PubMed/Corpus">001313</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001313</idno>
<idno type="wicri:Area/PubMed/Curation">001272</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001272</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001272</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001272</idno>
<idno type="wicri:Area/Ncbi/Merge">000116</idno>
<idno type="wicri:Area/Ncbi/Curation">000116</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000116</idno>
<idno type="wicri:doubleKey">0028-4793:2000:Rascol O:a:five:year</idno>
<idno type="wicri:Area/Main/Merge">003F38</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa.</title>
<author>
<name sortKey="Rascol, O" sort="Rascol, O" uniqKey="Rascol O" first="O" last="Rascol">O. Rascol</name>
<affiliation wicri:level="3">
<nlm:affiliation>Clinical Investigation Center, Neuropharmacology Unit, INSERM Unité 455, University Hospital, Toulouse, France. rascol@cict.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Clinical Investigation Center, Neuropharmacology Unit, INSERM Unité 455, University Hospital, Toulouse</wicri:regionArea>
<placeName>
<region type="region">Occitanie (région administrative)</region>
<region type="old region">Midi-Pyrénées</region>
<settlement type="city">Toulouse</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Brooks, D J" sort="Brooks, D J" uniqKey="Brooks D" first="D J" last="Brooks">D J Brooks</name>
</author>
<author>
<name sortKey="Korczyn, A D" sort="Korczyn, A D" uniqKey="Korczyn A" first="A D" last="Korczyn">A D Korczyn</name>
</author>
<author>
<name sortKey="De Deyn, P P" sort="De Deyn, P P" uniqKey="De Deyn P" first="P P" last="De Deyn">P P De Deyn</name>
</author>
<author>
<name sortKey="Clarke, C E" sort="Clarke, C E" uniqKey="Clarke C" first="C E" last="Clarke">C E Clarke</name>
</author>
<author>
<name sortKey="Lang, A E" sort="Lang, A E" uniqKey="Lang A" first="A E" last="Lang">A E Lang</name>
</author>
</analytic>
<series>
<title level="j">The New England journal of medicine</title>
<idno type="ISSN">0028-4793</idno>
<imprint>
<date when="2000" type="published">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged</term>
<term>Antiparkinson Agents (adverse effects)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>Disease-Free Survival</term>
<term>Double-Blind Method</term>
<term>Drug Therapy, Combination</term>
<term>Dyskinesia, Drug-Induced (epidemiology)</term>
<term>Dyskinesia, Drug-Induced (etiology)</term>
<term>Dyskinesia, Drug-Induced (prevention & control)</term>
<term>Female</term>
<term>Humans</term>
<term>Incidence</term>
<term>Indoles (adverse effects)</term>
<term>Indoles (therapeutic use)</term>
<term>Levodopa (adverse effects)</term>
<term>Levodopa (therapeutic use)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Prospective Studies</term>
<term>Risk Factors</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Antiparkinson Agents</term>
<term>Indoles</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antiparkinson Agents</term>
<term>Indoles</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Dyskinesia, Drug-Induced</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en">
<term>Dyskinesia, Drug-Induced</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Dyskinesia, Drug-Induced</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Disease-Free Survival</term>
<term>Double-Blind Method</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Humans</term>
<term>Incidence</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Prospective Studies</term>
<term>Risk Factors</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">There is debate about whether the initial treatment for patients with Parkinson's disease should be levodopa or a dopamine agonist.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003F38 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 003F38 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:10816186
   |texte=   A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i   -Sk "pubmed:10816186" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonFranceV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024